112 related articles for article (PubMed ID: 20673498)
1. [Interference of homologous sequences on the SNP study of CYP2A13 gene].
Hua F; Wan H; Mei C; Zheng D; Sun L; Chen J; Liu H; Zhou Q
Zhongguo Fei Ai Za Zhi; 2010 Feb; 13(2):94-7. PubMed ID: 20673498
[TBL] [Abstract][Full Text] [Related]
2. Novel single nucleotide polymorphism of the CYP2A13 gene in Japanese individuals.
Tamaki Y; Honda M; Muroi Y; Arai T; Sugimura H; Matsubara Y; Kanno S; Ishikawa M; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2011; 26(5):544-7. PubMed ID: 21606606
[TBL] [Abstract][Full Text] [Related]
3. Arg257Cys polymorphism of CYP2A13 in a Chinese population.
Cheng XY; Chen GL; Zhang WX; Zhou G; Wang D; Zhou HH
Clin Chim Acta; 2004 May; 343(1-2):213-6. PubMed ID: 15115698
[TBL] [Abstract][Full Text] [Related]
4. Development of a real-time polymerase chain reaction-based method for the measurement of relative allelic expression and identification of CYP2A13 alleles with decreased expression in human lung.
Zhang X; Caggana M; Cutler TL; Ding X
J Pharmacol Exp Ther; 2004 Oct; 311(1):373-81. PubMed ID: 15175424
[TBL] [Abstract][Full Text] [Related]
5. The effects of single nucleotide polymorphisms in CYP2A13 on metabolism of 5-methoxypsoralen.
Goto T; Moriuchi H; Fu X; Ikegawa T; Matsubara T; Chang G; Uno T; Morigaki K; Isshiki K; Imaishi H
Drug Metab Dispos; 2010 Dec; 38(12):2110-6. PubMed ID: 20798279
[TBL] [Abstract][Full Text] [Related]
6. Multiplex genotyping of cytochrome p450 single-nucleotide polymorphisms by use of MALDI-TOF mass spectrometry.
Misra A; Hong JY; Kim S
Clin Chem; 2007 May; 53(5):933-9. PubMed ID: 17384008
[TBL] [Abstract][Full Text] [Related]
7. HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers.
Hua F; Guo Y; Sun Q; Yang L; Gao F
Thorac Cancer; 2019 Apr; 10(4):601-606. PubMed ID: 30807688
[TBL] [Abstract][Full Text] [Related]
8. Key residues controlling binding of diverse ligands to human cytochrome P450 2A enzymes.
DeVore NM; Smith BD; Wang JL; Lushington GH; Scott EE
Drug Metab Dispos; 2009 Jun; 37(6):1319-27. PubMed ID: 19251817
[TBL] [Abstract][Full Text] [Related]
9. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant.
Zhang X; Su T; Zhang QY; Gu J; Caggana M; Li H; Ding X
J Pharmacol Exp Ther; 2002 Aug; 302(2):416-23. PubMed ID: 12130698
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of differential expression of the CYP2A13 7520C and 7520G alleles in human lung: allelic expression analysis for CYP2A13 heterogeneous nuclear RNA, and evidence for the involvement of multiple cis-regulatory single nucleotide polymorphisms.
Wu H; Zhang X; Ling G; D'Agostino J; Ding X
Pharmacogenet Genomics; 2009 Nov; 19(11):852-63. PubMed ID: 20431511
[TBL] [Abstract][Full Text] [Related]
12. The missense genetic polymorphisms of human CYP2A13: functional significance in carcinogen activation and identification of a null allelic variant.
Wang SL; He XY; Shen J; Wang JS; Hong JY
Toxicol Sci; 2006 Nov; 94(1):38-45. PubMed ID: 16917071
[TBL] [Abstract][Full Text] [Related]
13. Eighteen novel polymorphisms of the CYP2A13 gene in Japanese.
Fujieda M; Yamazaki H; Kiyotani K; Muroi A; Kunitoh H; Dosaka-Akita H; Sawamura Y; Kamataki T
Drug Metab Pharmacokinet; 2003; 18(1):86-90. PubMed ID: 15618722
[TBL] [Abstract][Full Text] [Related]
14. Oxidation of 1-chloropyrene by human CYP1 family and CYP2A subfamily cytochrome P450 enzymes: catalytic roles of two CYP1B1 and five CYP2A13 allelic variants.
Shimada T; Murayama N; Kakimoto K; Takenaka S; Lim YR; Yeom S; Kim D; Yamazaki H; Guengerich FP; Komori M
Xenobiotica; 2018 Jun; 48(6):565-575. PubMed ID: 28648140
[TBL] [Abstract][Full Text] [Related]
15. Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers.
D'Agostino J; Zhang X; Wu H; Ling G; Wang S; Zhang QY; Liu F; Ding X
Drug Metab Dispos; 2008 Nov; 36(11):2316-23. PubMed ID: 18669584
[TBL] [Abstract][Full Text] [Related]
16. Identification of 5-hydroxymethylfurfural in cigarette smoke extract as a new substrate metabolically activated by human cytochrome P450 2A13.
Ji M; Zhang Z; Li N; Xia R; Wang C; Yu Y; Yao S; Shen J; Wang SL
Toxicol Appl Pharmacol; 2018 Nov; 359():108-117. PubMed ID: 30253172
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 2A13 is an efficient enzyme in metabolic activation of aflatoxin G1 in human bronchial epithelial cells.
Zhang Z; Yang X; Wang Y; Wang X; Lu H; Zhang X; Xiao X; Li S; Wang X; Wang SL
Arch Toxicol; 2013 Sep; 87(9):1697-707. PubMed ID: 23907605
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of a novel CYP2A13--transgenic mouse model.
Jia K; Li L; Liu Z; Hartog M; Kluetzman K; Zhang QY; Ding X
Drug Metab Dispos; 2014 Aug; 42(8):1341-8. PubMed ID: 24907355
[TBL] [Abstract][Full Text] [Related]
19. Key residues controlling phenacetin metabolism by human cytochrome P450 2A enzymes.
DeVore NM; Smith BD; Urban MJ; Scott EE
Drug Metab Dispos; 2008 Dec; 36(12):2582-90. PubMed ID: 18779312
[TBL] [Abstract][Full Text] [Related]
20. An investigation of the catalytic activity of CYP2A13*4 with coumarin and polymorphisms of CYP2A13 in a Chinese Han population.
Liu T; Hong Y; Li Z; Hong J; Zeng S; Zheng M; Chen S
Drug Metab Dispos; 2012 May; 40(5):847-51. PubMed ID: 22315333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
